Dr. Luke Discusses Combination Approaches on Horizon in Melanoma

Jason J. Luke, MD
Published: Thursday, Sep 17, 2015



Jason J. Luke, MD, assistant professor of Medicine, University of Chicago Medicine, discusses combination approaches that are on the horizon for the treatment of patients with melanoma.

Oncologists are starting to think about the development of combination therapies for patients with melanoma who have inflamed tumor microenvironments. Possible combinations to further augment these T cells, Luke explains, include oncolytic viruses, IDO inhibitors, and additional immune checkpoints.

However, this contrasts for patients without inflamed tumor microenvironments, because T cells need to be inserted into the tumors for PD-1/PD-L1 agents to be effective. Combination approaches for this subgroup include radiation and/or vaccines, Luke says. These two subgroups are helping oncologists think differently about drug development to maximize benefit for patients based on their immunological status, not only their molecular status.



Jason J. Luke, MD, assistant professor of Medicine, University of Chicago Medicine, discusses combination approaches that are on the horizon for the treatment of patients with melanoma.

Oncologists are starting to think about the development of combination therapies for patients with melanoma who have inflamed tumor microenvironments. Possible combinations to further augment these T cells, Luke explains, include oncolytic viruses, IDO inhibitors, and additional immune checkpoints.

However, this contrasts for patients without inflamed tumor microenvironments, because T cells need to be inserted into the tumors for PD-1/PD-L1 agents to be effective. Combination approaches for this subgroup include radiation and/or vaccines, Luke says. These two subgroups are helping oncologists think differently about drug development to maximize benefit for patients based on their immunological status, not only their molecular status.




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Publication Bottom Border
Border Publication
x